Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;123(6):583-8.
doi: 10.1007/s00702-016-1552-3. Epub 2016 Apr 20.

The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease

Affiliations

The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease

Daphne Robakis et al. J Neural Transm (Vienna). 2016 Jun.

Abstract

The H1 haplotype of the microtubule-associated protein tau gene (MAPT) is associated with an increased risk of Parkinson disease (PD) compared with the H2 haplotype, but its effect on Lewy body (LB) formation is unclear. In this study, we compared the MAPT haplotype frequency between pathologically confirmed PD patients (n = 71) and controls (n = 52). We analyzed Braak LB stage, Braak neurofibrillary tangle (NFT) stage, and CERAD amyloid score by haplotype. We further tested the association between MAPT haplotype and semi-quantitative counts of LBs, NFTs, and neuritic plaques (NPs) in multiple neocortical regions. Consistent with previous reports, PD cases had an increased likelihood of carrying an H1/H1 genotype compared to controls (OR = 5.72, 95 % CI 1.80-18.21, p = 0.003). Braak LB, Braak NFT and CERAD scores did not differ by haplotype. However, H1/H1 carriers had higher LB counts in parietal cortex (p = 0.02) and in overall neocortical LBs (p = 0.03) compared to non-H1/H1 cases. Our analyses suggest that PD patients homozygous for the H1 haplotype have a higher burden of neocortical LB pathology.

Keywords: Lewy body; MAPT haplotype; Neuropathology; Parkinson’s disease; Tau.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards

Conflict of interest The authors declare that there are no conflicts of interest and no competing financial interests.

Figures

Fig. 1
Fig. 1
Total neocortical LB score in H1/H1 vs H2 PD patients. Total neocortical LB score for each patient is plotted. Lines represent median and interquartile range

References

    1. Allen M, et al. Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels. Alzheimers Res Ther. 2014;6:39. - PMC - PubMed
    1. Arima K, et al. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson’s disease and in dementia with Lewy bodies. Brain Res. 1999;843:53–61. - PubMed
    1. Badiola N, et al. Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS One. 2011;6:e26609. - PMC - PubMed
    1. Baker M, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8:711–715. - PubMed
    1. Bekris LM, Mata IF, Zabetian CP. The genetics of Parkinson disease. J Geriatr Psychiatry Neurol. 2010;23:228–242. - PMC - PubMed

Publication types

LinkOut - more resources